Home/ Supplements/ Omega 3/ DHA Capsule

DHA Capsule

product on market Capsule Gesticare Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic Acid and Eicosapentaenoic Acid are omega-3 fatty acids with strong evidence supporting their role in cardiovascular and cognitive health. Research indicates these ingredients help maintain healthy triglyceride levels and support brain function. Evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DHA Capsule
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Gelatin Capsule(s)
Serving Size
Multi-Vitamin and Mineral (MVM)
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

high Oleic Sunflower Oil Ascorbyl Palmitate Tocopherols Gelatin Glycerin Polysorbate 80
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Dosage and Administration: One Gesticare(R) tablet and one DHA capsule daily or as directed by a physician.

One tablet and one capsule daily or as directed by physician

Warnings & Precautions

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Warnings: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Precautions: Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.

Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Do not use if blister seal is broken.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Formulation Notes

Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline

Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline

Indications and Usage: Gesticare(R) DHA is indicated to provide vitamin/mineral and DHA omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Gesticare(R) DHA may be beneficial in improving the nutritional status of women prior to conception.

Additional Information

Not for Sale - Rx Only

life'sDHA(TM) HEALTHY BRAIN, EYES, HEART

How Supplied: Gesticare(R) DHA is supplied as six child-resistant blister cards containing 5 Gesticare(R) tablets and 5 DHA capsules each - NDC 18860-253-30.

Store at controlled room temperature 20(0)-25(0)C (68(0)-77(0)F); excursions permitted to 15(0)- 30(0)C (59(0)- 86(0)F).

NDC 18860-253-30 (30 count) 6 blister cards; each containing 5 tablets and 5 capsules

GDHA1-11-03

PHYSICIAN'S SAMPLES (NDC 18860-253-00)

Contains 6 Patient Starter packages, each containing 2 tablets and 2 capsules

GDHA1-11-04

DHA is an omega-3 fatty acid.

625 mg of Algal Oil is equivalent to250 mg of DHA.

Metadata

Product Details

UPC / SKU3 18860 25330 7
DSLD Entry Date2015-03-25
Product TypeMulti-Vitamin and Mineral (MVM)
FormCapsule
DSLD ID43186
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.